HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jean-Louis Pujol Selected Research

Carboplatin (JM8)

10/2020Switch maintenance chemotherapy versus observation after carboplatin and weekly paclitaxel doublet chemotherapy in elderly patients with advanced non-small cell lung cancer: IFCT-1201 MODEL trial.
11/2011Randomized phase II study of dulanermin in combination with paclitaxel, carboplatin, and bevacizumab in advanced non-small-cell lung cancer.
5/2006Weekly paclitaxel combined with monthly carboplatin in elderly patients with advanced non-small cell lung cancer: a multicenter phase II study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jean-Louis Pujol Research Topics

Disease

37Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2022 - 08/2002
16Neoplasms (Cancer)
01/2020 - 02/2007
14Lung Neoplasms (Lung Cancer)
04/2021 - 07/2002
9Neutropenia
10/2015 - 06/2006
7Small Cell Lung Carcinoma (Small Cell Lung Cancer)
11/2020 - 02/2003
6Disease Progression
01/2020 - 03/2012
6Fatigue
01/2019 - 05/2007
6Anemia
11/2014 - 05/2007
3Nausea
11/2014 - 06/2006
3Infections
11/2012 - 05/2007
3Febrile Neutropenia
03/2012 - 06/2006
2Adenocarcinoma of Lung
01/2020 - 01/2020
2Thrombocytopenia (Thrombopenia)
05/2007 - 05/2007
2Diarrhea
05/2007 - 06/2006
2Vomiting
05/2007 - 06/2006
1Breast Neoplasms (Breast Cancer)
11/2021
1Cardiovascular Diseases (Cardiovascular Disease)
04/2021
1Thrombosis (Thrombus)
04/2021
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
10/2020
1Sarcopenia
01/2020
1Cachexia
01/2020
1Death (Near-Death Experience)
01/2018
1Melanoma (Melanoma, Malignant)
12/2016
1Weight Loss (Weight Reduction)
01/2016
1Edema (Dropsy)
11/2014
1Hypoxia (Hypoxemia)
05/2012
1Carcinoma (Carcinomatosis)
05/2012
1Neoplasm Metastasis (Metastasis)
11/2011
1Brain Neoplasms (Brain Tumor)
06/2010
1Lung Diseases (Lung Disease)
08/2008
1Sepsis (Septicemia)
05/2007
1Stomatitis
05/2007
1Asthenia
06/2006
1Constipation
06/2006
1Fever (Fevers)
06/2006
1Exanthema (Rash)
06/2006

Drug/Important Bio-Agent (IBA)

13Cisplatin (Platino)FDA LinkGeneric
10/2018 - 08/2002
9PlatinumIBA
11/2021 - 08/2002
9Pemetrexed (MTA)FDA Link
10/2020 - 05/2007
5Paclitaxel (Taxol)FDA LinkGeneric
10/2020 - 05/2006
5GemcitabineFDA Link
10/2020 - 08/2002
5Proteins (Proteins, Gene)FDA Link
01/2017 - 08/2008
4Biomarkers (Surrogate Marker)IBA
11/2019 - 02/2003
4Vinorelbine (Navelbine)FDA LinkGeneric
01/2019 - 06/2006
4AntigensIBA
12/2016 - 02/2007
3Immune Checkpoint InhibitorsIBA
04/2021 - 01/2020
3Carboplatin (JM8)FDA LinkGeneric
10/2020 - 05/2006
3Docetaxel (Taxotere)FDA Link
06/2015 - 05/2007
2LigandsIBA
11/2021 - 01/2019
2atezolizumabIBA
11/2020 - 01/2019
2Darbepoetin alfa (Aranesp)FDA Link
01/2020 - 04/2008
2Tyrosine Kinase InhibitorsIBA
01/2020 - 01/2019
2Gefitinib (Iressa)FDA Link
01/2020 - 06/2006
2Neoplasm Antigens (Tumor Antigens)IBA
12/2016 - 12/2011
2Pharmaceutical PreparationsIBA
08/2013 - 11/2012
2AutoantibodiesIBA
12/2011 - 05/2011
2Antineoplastic Agents (Antineoplastics)IBA
06/2011 - 04/2010
1durvalumabIBA
01/2022
1canakinumabFDA Link
04/2021
1pembrolizumabIBA
04/2021
1Circulating Tumor DNAIBA
11/2020
1B7-H1 AntigenIBA
01/2020
1Therapeutic UsesIBA
01/2020
1osimertinibIBA
01/2020
1Aurora Kinase AIBA
10/2018
1Threonine (L-Threonine)FDA Link
10/2018
1Temozolomide (Temodar)FDA LinkGeneric
10/2018
1Etoposide (VP 16)FDA LinkGeneric
10/2018
1Serine (L-Serine)FDA Link
10/2018
1Anaplastic Lymphoma KinaseIBA
10/2017
1DNA (Deoxyribonucleic Acid)IBA
01/2017
1Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA
01/2017
1A-Form DNA (A-DNA)IBA
01/2017
1Poly(ADP-ribose) Polymerase InhibitorsIBA
01/2017
1DisulfidesIBA
01/2015
1Glycoproteins (Glycoprotein)IBA
01/2015
1Cetuximab (Erbitux)FDA Link
02/2014
1TubulinIBA
05/2012
1Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
05/2012
1Small Interfering RNA (siRNA)IBA
05/2012
1Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA
05/2012
1IfosfamideFDA LinkGeneric
02/2012
1Epirubicin (Ellence)FDA LinkGeneric
02/2012
1Bevacizumab (Avastin)FDA Link
11/2011
1human TNFSF10 proteinIBA
11/2011
1Cytochrome P-450 Enzyme System (Cytochrome P450)IBA
04/2010
1AlkaloidsIBA
10/2007
1Topotecan (Hycamtin)FDA LinkGeneric
05/2007
1AntibodiesIBA
02/2007
1Platinum Compounds (Compounds, Platinum)IBA
09/2005

Therapy/Procedure

28Drug Therapy (Chemotherapy)
11/2021 - 08/2002
15Therapeutics
10/2020 - 04/2003
3Chemoradiotherapy
01/2022 - 06/2010
3Adjuvant Chemotherapy
11/2019 - 06/2015
2Neoadjuvant Therapy
04/2021 - 05/2012
2Precision Medicine
10/2018 - 01/2017
1Maintenance Chemotherapy
10/2020
1Immunotherapy
01/2020
1Radiotherapy
06/2010
1Highly Active Antiretroviral Therapy (HAART)
04/2010